These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1574607)

  • 1. Effects of thyrotropin releasing hormone and its analogues on unconsciousness following head injury in mice.
    Tanaka K; Ogawa N; Chou H; Mori A; Yanaihara N
    Regul Pept; 1992 Mar; 38(2):129-33. PubMed ID: 1574607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential anti-depressive effects of thyrotropin releasing hormone (TRH) and its analogues.
    Ogawa N; Mizuno S; Mori A; Nukina I; Ota Z; Yamamoto M
    Peptides; 1984; 5(4):743-6. PubMed ID: 6436797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyrotropin releasing hormone prevents abnormalities of cortical acetylcholine and monoamines in mice following head injury.
    Tanaka K; Ogawa N; Asanuma M; Kondo Y
    Regul Pept; 1997 Jun; 70(2-3):173-8. PubMed ID: 9272630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gamma-butyrolactone-gamma-carbonyl-histidyl-prolinamide citrate (DN-1417): a novel TRH analog with potent effects on the central nervous system.
    Miyamoto M; Fukuda N; Narumi S; Nagai Y; Saji Y; Nagawa Y
    Life Sci; 1981 Feb; 28(8):861-9. PubMed ID: 6783804
    [No Abstract]   [Full Text] [Related]  

  • 5. Analogs of thyrotropin-releasing hormone in potentiating the spinal monosynaptic reflex in vitro.
    Deshpande SB; Warnick JE
    Eur J Pharmacol; 1994 Dec; 271(2-3):439-44. PubMed ID: 7705444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of MK-771 on the isolated amphibian spinal cord: comparison with thyrotropin-releasing hormone.
    Yarbrough GG; Singh DK
    Can J Physiol Pharmacol; 1979 Aug; 57(8):920-2. PubMed ID: 115561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in rat regional brain cyclic nucleotides by thyrotropin-releasing hormone (TRH) and its analog DN-1417.
    Narumi S; Nagai Y; Saji Y; Nagawa Y
    Jpn J Pharmacol; 1983 Oct; 33(5):915-26. PubMed ID: 6139495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal absorption mechanisms of gamma-butyrolactone-gamma-carbonyl-L-histidyl-L-prolinamide citrate (DN-1417) and thyrotropin-releasing hormone (TRH).
    Yokohama S; Yoshioka T; Kitamori N; Shimamoto T; Kamada A
    J Pharmacobiodyn; 1985 Apr; 8(4):278-85. PubMed ID: 3928869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-6-ketopiperidine-2-carbonyl-L-leucyl-L-proline amide as a novel thyrotropin releasing hormone analogue with improving effects on impaired central nervous systems functions.
    Oka M; Ochi Y; Furukawa K; Ito T; Miura Y; Karasawa T; Kadokawa T
    Arzneimittelforschung; 1989 Mar; 39(3):297-303. PubMed ID: 2547386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracerebroventricular injection of a TRH analogue, gamma-butyrolactone-gamma-carbonyl-L-histidyl-prolinamide, induces gastric lesions and gastric acid stimulation in rats.
    Maeda-Hagiwara M; Watanabe H
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Aug; 330(2):142-6. PubMed ID: 3930976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro thyrotrophin release with thyrotropin-releasing hormone and an analogue, DN-1417.
    Shiota K; Yoshida K; Noguchi C; Nakayama R
    Acta Endocrinol (Copenh); 1984 May; 106(1):71-8. PubMed ID: 6428117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of thyrotropin releasing hormone, MK-771 and DN-1417 on morphine abstinence syndrome.
    Bhargava HN; Matwyshyn GA
    Psychopharmacology (Berl); 1985; 87(2):141-6. PubMed ID: 2996045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [TRH and its analog (DN-1417). Effects on central dopaminergic system-dependent behaviors in rats and mice].
    Miyamoto M; Saji Y; Nagawa Y
    Nihon Yakurigaku Zasshi; 1985 Mar; 85(3):129-41. PubMed ID: 3924793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of TRH and TRH analogues on the central regulation of breathing in the rat.
    Hedner J; Hedner T; Wessberg P; Lundberg D; Jonason J
    Acta Physiol Scand; 1983 Mar; 117(3):427-37. PubMed ID: 6410685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of interaction between thyrotropin releasing hormone and its analogs with 3H-quinuclidinyl benzilate recognition sites in the rat striatum.
    Das S; Bhargava HN
    Neuropharmacology; 1985 Jul; 24(7):681-3. PubMed ID: 3927185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the neuropharmacology of thyrotropin releasing hormone (TRH) and a new TRH analog.
    Yarbrough GG
    Eur J Pharmacol; 1978 Mar; 48(1):19-27. PubMed ID: 416961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A possible mechanism of action of thyrotropin-releasing hormone (TRH) and its analog DN-1417 on the release of dopamine from the nucleus accumbens and striatum in rats.
    Narumi S; Nagai Y; Saji Y; Nagawa Y
    Jpn J Pharmacol; 1985 Dec; 39(4):425-35. PubMed ID: 2869169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyrotropin-releasing hormone and its analog MK-771 increase the cerebroventricular perfusate content of dihydroxyphenylacetic acid.
    Nielsen JA; Moore KE
    J Neurochem; 1984 Aug; 43(2):593-6. PubMed ID: 6429282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotensin-induced antinociception and hypothermia in mice: antagonism by TRH and structural analogs of TRH.
    Hernandez DE; Nemeroff CB; Valderrama MH; Prange AJ
    Regul Pept; 1984 Jan; 8(1):41-9. PubMed ID: 6425994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the novel thyrotropin-releasing hormone analogue Na -((1S,2R)-2-methyl-4-oxocyclopentylcarbonyl)-L-histidyl-L-prol ina mide monohydrate on the central nervous system in mice and rats.
    Matsushita M; Yonemori F; Furukawa N; Ohta A; Toide K; Uchida I; Iwata K
    Arzneimittelforschung; 1993 Aug; 43(8):813-7. PubMed ID: 8216433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.